CNF Investments

CNF Investments, LLC is a private investment firm specializing in venture capital and private equity opportunities, managing over $350 million in capital. The firm invests in sectors such as technology, healthcare, and energy, considering both direct investments and fund investments. CNF primarily targets growth-stage companies but is also open to early and late-stage investments. The firm emphasizes collaboration with experienced entrepreneurs and co-investors to foster the development of successful companies. CNF employs thorough diligence processes, concentrating its analysis on the management teams and key players involved in potential investments. The firm believes that achieving success relies on a strategic combination of talent, experience, dedication, focus, and execution. CNF is affiliated with Clark Enterprises, Inc.

Robert J. Flanagan

Executive Vice President

46 past transactions

Ceros

Series C in 2019
Ceros is a cloud-based platform that specializes in experiential content creation, allowing marketers and designers to develop rich, interactive content without the need for coding or traditional web development. The software functions as a design studio that facilitates real-time collaboration on digital projects, enabling users to easily create and publish engaging content with just a click. This empowers brands to effectively share their stories and connect with their audiences in a dynamic manner.

Svelte Medical Systems

Venture Round in 2018
Svelte Medical Systems, Inc. specializes in the design, development, and commercialization of balloon-expandable stents aimed at patients undergoing percutaneous coronary intervention (PCI) for atherosclerosis treatment. The company offers the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire system that simplifies catheter use for transradial interventions, and the DIRECT Rapid Exchange System, which employs proprietary balloon designs to improve direct stenting and post-dilatation processes. Founded in 2007 by Robert, David, and Tim Fischell, Svelte is committed to addressing critical clinical challenges in the coronary stent market, focusing on enhancing stent deliverability, reducing costs, and improving device safety. The company has developed one of the lowest profile and most deliverable stents available, featuring advanced technology aimed at achieving better clinical outcomes for patients. Based in New Providence, New Jersey, Svelte operates within the $5 billion coronary stent market.

Ceros

Series B in 2016
Ceros is a cloud-based platform that specializes in experiential content creation, allowing marketers and designers to develop rich, interactive content without the need for coding or traditional web development. The software functions as a design studio that facilitates real-time collaboration on digital projects, enabling users to easily create and publish engaging content with just a click. This empowers brands to effectively share their stories and connect with their audiences in a dynamic manner.

Svelte Medical Systems

Private Equity Round in 2016
Svelte Medical Systems, Inc. specializes in the design, development, and commercialization of balloon-expandable stents aimed at patients undergoing percutaneous coronary intervention (PCI) for atherosclerosis treatment. The company offers the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire system that simplifies catheter use for transradial interventions, and the DIRECT Rapid Exchange System, which employs proprietary balloon designs to improve direct stenting and post-dilatation processes. Founded in 2007 by Robert, David, and Tim Fischell, Svelte is committed to addressing critical clinical challenges in the coronary stent market, focusing on enhancing stent deliverability, reducing costs, and improving device safety. The company has developed one of the lowest profile and most deliverable stents available, featuring advanced technology aimed at achieving better clinical outcomes for patients. Based in New Providence, New Jersey, Svelte operates within the $5 billion coronary stent market.

Blitsy

Series B in 2016
Blitsy, Inc. is an online retailer specializing in arts and crafts, founded in 2011 and based in Chicago, Illinois. The company offers a comprehensive platform where creative individuals can shop for craft supplies and tools, as well as access instructional videos for various DIY projects. Blitsy focuses on providing a curated shopping experience through limited-time sale events, enhancing the value and inspiration for its customers. As of November 2017, Blitsy operates as a subsidiary of Nicole Crafts LLC, further solidifying its presence in the arts and crafts market.

Upskill

Venture Round in 2015
Upskill, Inc. is a technology company specializing in augmented reality software tailored for the industrial workforce. Founded in 2010 and based in Vienna, Virginia, with additional offices in Cambridge and San Francisco, Upskill offers the Skylight platform, which enables organizations to create applications for smart glasses. This platform connects workers across various industries—including healthcare, manufacturing, retail, and logistics—with essential information, processes, and tools, allowing them to perform tasks more efficiently and accurately. Upskill's solutions facilitate hands-free operation, thereby enhancing productivity, quality, and compliance in competitive environments. The company was previously known as APX Labs, LLC before rebranding in January 2017.

Kareo

Series G in 2015
Kareo is the leading cloud-based, clinical and business management platform designed specifically for the independent practice. Kareo’s integrated modules work together as part of a seamless platform, so independent practices have helpful tools to tackle their toughest administrative challenges. These tools include electronic health records, practice management, billing, marketing and patient engagement software. Plus, proven, integrated third-party applications and services in Kareo Marketplace to make delivering care even easier. Today we help over 50,000 providers in all 50 states run more efficient and profitable practices, while delivering outstanding patient care. Kareo has received extensive industry recognition, including being awarded the 2018 United States Ambulatory EHR Enabling Technology Leadership Award from Frost and Sullivan, Deloitte Technology Fast 500, Inc. 5000 and Black Book’s #1 Integrated EHR, Practice Management and Medical Billing Vendor. With offices across the country, our mission is to help independent practices succeed in an ever-changing healthcare market.

CircleBack

Series C in 2015
CircleBack, Inc. is a technology company based in Vienna, Virginia, focused on improving contact data accuracy for business consumers. Founded in 2008, the company develops mobile contact intelligence applications that streamline the management of address books across various devices. Its flagship product, CircleBack, uses a patented data engine to provide real-time updates on connections, such as job changes and new contact information, directly to users' mobile address books and customer relationship management systems. Additionally, CircleBack offers tools like ContactSaver, which converts email signatures into contacts for Gmail, and ScanBizCards, enabling users to digitize business cards. The Cleanup Suite helps refine contact lists by removing duplicates. CircleBack aims to enhance productivity by ensuring that professionals and businesses can maintain accurate and up-to-date connections.

Ingo Money

Venture Round in 2015
Ingo Money, Inc. is a financial technology company based in Alpharetta, Georgia, that specializes in digital payment solutions. Founded in 2001 and formerly known as CHEXAR Networks, Inc., Ingo Money provides a mobile application that allows users to cash various types of checks, including paychecks and personal checks, directly from their devices. The company offers several services, including Ingo Push, which provides instant loan proceeds to small businesses; Ingo Check, a service for digital disbursements; and Ingo Cash, which enables users to convert cash into real-time digital deposits and payments. Additionally, Ingo Money QuickConnect allows businesses to offer instant payments through push-to-card options. With a mission to digitize paper checks and facilitate safe-to-spend funds, Ingo Money serves a wide range of clients, including fintech companies, banks, and other businesses, enhancing the overall payment experience while reducing costs and delays.

Vascular Therapies

Private Equity Round in 2015
Vascular Therapies, Inc. is a biopharmaceutical company founded in 2001 and based in Cresskill, New Jersey. The company focuses on developing and commercializing innovative treatments to meet significant clinical needs for patients requiring vascular access for hemodialysis. Its lead product candidate, which incorporates sirolimus, has received orphan drug designations in both the United States and the European Union for dialysis vascular access. Vascular Therapies aims to improve patient outcomes through its therapies, which include biodegradable collagen implants designed to address vascular anastomosis failure and enhance the effectiveness of arteriovenous fistulas.

Orchestro

Venture Round in 2014
Orchestro, Inc. is a provider of a Software-as-a-Service demand signal management platform designed for consumer packaged goods companies. Founded in 1999 and based in McLean, Virginia, the company specializes in data harmonization, facilitating in-store execution, new product introductions, on-shelf availability, promotion execution, and replenishment needs. Its platform consolidates point-of-sale, internal, and syndicated data, enabling users such as category analysts, national account managers, and international representatives to create informative dashboards. Orchestro was previously known as Vision Chain, Inc. and adopted its current name in February 2013. As of June 2016, it operates as a subsidiary of E2open, Inc.

Echo360

Series C in 2014
Echo360, Inc. is a developer of a Software-as-a-Service learning and analytics platform tailored for higher education institutions both in the United States and internationally. Founded in 2007 and headquartered in Virginia, the company offers a comprehensive solution that enables users to capture, share, and enhance classroom experiences through features such as polls, quizzes, and instructional video recordings. Its platform facilitates connections between students and instructors worldwide and provides learning analytics to identify student engagement levels and potential challenges before exams. Additionally, Echo360 includes a learning library for storing educational materials, universal capture software for recording content on various devices, and an automatic speech recognition solution to support video-based learning. The company aims to transform educational experiences by leveraging active learning technology and interactive software to engage students effectively.

AnyPresence

Series B in 2014
AnyPresence is an enterprise platform focused on streamlining the mobile-enabling process for businesses. It allows organizations to quickly assemble and deploy backend servers and mobile applications for iOS, Android, and HTML5, all while providing 100% native, portable source code. The platform features a patent-pending technology that facilitates the generation of sample mobile apps directly from API management portals, enhancing app adoption and reducing time-to-market for applications that utilize company data and services. Additionally, AnyPresence supports the development of APIs and cross-platform applications within a cloud-based environment, ensuring adherence to IT governance and best practices. Its user-friendly design offers flexibility for source code-level customization and options for on-premise hosting, making it suitable for various enterprise needs.

Surfwatch Labs

Series A in 2014
SurfWatch Labs, Inc. provides cyber risk intelligence solutions aimed at helping organizations mitigate their cyber threats. Founded in 2012 and based in Sterling, Virginia, the company offers a suite of software-as-a-service (SaaS) products, including SurfWatch Risk Monitor, which delivers a continuously updated cybercrime risk score, risk reports, industry insights, and solution recommendations. Additionally, SurfWatch Market identifies relevant cyber solutions tailored to an organization’s specific security challenges. The company also develops SurfWatch Analytics, which collects and analyzes cyber-related information from various sources to provide timely risk intelligence. By combining analytics and human expertise, SurfWatch Labs enables organizations and service providers to establish effective cyber threat intelligence operations, enhancing their overall cybersecurity posture.

Closely

Series A in 2014
Closely focuses on supporting small, local merchants by providing tools that enhance their social and mobile marketing efforts. The company offers the Perch App, a mobile-first platform designed to simplify the complexities of various social media channels. This app helps business owners identify key customer signals and understand their competitive standing, allowing them to make informed decisions for improvement. By equipping merchants with these resources, Closely enables them to effectively engage with their customers, build loyalty, and optimize their marketing strategies, ultimately enhancing their presence in the local marketplace.

Quad Learning

Series B in 2014
Quad Learning, Inc., operating as American Honors, was founded in 2012 and is based in Washington, D.C. The company focuses on creating more affordable pathways for students seeking to complete their bachelor's degrees at prestigious institutions. It develops a two-year honors program tailored for high-achieving students, offering essential academic support and personalized advising services, including course planning and career exploration. Additionally, Quad Learning collaborates with community colleges to deliver this competitive program, providing marketing strategies, recruitment, selective admissions, and faculty development services. The company also features an online learning platform, enhancing the educational experience for students and facilitating their transition to four-year universities.

Svelte Medical Systems

Venture Round in 2014
Svelte Medical Systems, Inc. specializes in the design, development, and commercialization of balloon-expandable stents aimed at patients undergoing percutaneous coronary intervention (PCI) for atherosclerosis treatment. The company offers the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire system that simplifies catheter use for transradial interventions, and the DIRECT Rapid Exchange System, which employs proprietary balloon designs to improve direct stenting and post-dilatation processes. Founded in 2007 by Robert, David, and Tim Fischell, Svelte is committed to addressing critical clinical challenges in the coronary stent market, focusing on enhancing stent deliverability, reducing costs, and improving device safety. The company has developed one of the lowest profile and most deliverable stents available, featuring advanced technology aimed at achieving better clinical outcomes for patients. Based in New Providence, New Jersey, Svelte operates within the $5 billion coronary stent market.

Speek

Series A in 2014
Speek Inc. is a provider of web-based conference calling solutions based in Dulles, Virginia. Founded in 2006, the company simplifies the conference calling experience by offering users a personal link that eliminates the need for dial-ins, pins, or downloads. Participants can join calls easily by clicking on a unique Speek link, allowing for seamless access via phone or web browser. The platform features a visual interface where users can see who has joined the call, identify active speakers, and share files. In its efforts to enhance its services, Speek has raised a total of $2.6 million in funding, including a recent $1.1 million in bridge funding. As of June 2015, Speek operates as a subsidiary of Jive Communications, Inc.

Kareo

Series F in 2014
Kareo is the leading cloud-based, clinical and business management platform designed specifically for the independent practice. Kareo’s integrated modules work together as part of a seamless platform, so independent practices have helpful tools to tackle their toughest administrative challenges. These tools include electronic health records, practice management, billing, marketing and patient engagement software. Plus, proven, integrated third-party applications and services in Kareo Marketplace to make delivering care even easier. Today we help over 50,000 providers in all 50 states run more efficient and profitable practices, while delivering outstanding patient care. Kareo has received extensive industry recognition, including being awarded the 2018 United States Ambulatory EHR Enabling Technology Leadership Award from Frost and Sullivan, Deloitte Technology Fast 500, Inc. 5000 and Black Book’s #1 Integrated EHR, Practice Management and Medical Billing Vendor. With offices across the country, our mission is to help independent practices succeed in an ever-changing healthcare market.

Viridis Learning

Seed Round in 2013
Viridis Learning, Inc. is an education technology company specializing in workforce education and human capital solutions for the middle-skill workforce. The company operates a platform that facilitates training, certification, and job placement for individuals seeking to enter, sustain, or advance in middle-skill occupations. Through its human capital technology solution, Viridis, the company addresses skill deficiencies by aligning training programs with the needs of local employers. The training offerings include a variety of courses such as Residential Concrete Specialization, Energy Management and Controls, and Advanced Residential Construction Supervisor, among others. With its base in New York, New York, Viridis Learning aims to enhance the employability of individuals while meeting the demands of employers in the middle-skill labor market.

Speek

Seed Round in 2013
Speek Inc. is a provider of web-based conference calling solutions based in Dulles, Virginia. Founded in 2006, the company simplifies the conference calling experience by offering users a personal link that eliminates the need for dial-ins, pins, or downloads. Participants can join calls easily by clicking on a unique Speek link, allowing for seamless access via phone or web browser. The platform features a visual interface where users can see who has joined the call, identify active speakers, and share files. In its efforts to enhance its services, Speek has raised a total of $2.6 million in funding, including a recent $1.1 million in bridge funding. As of June 2015, Speek operates as a subsidiary of Jive Communications, Inc.

ReelGenie

Seed Round in 2013
ReelGenie, LLC offers an online platform that allows users to create videos from their photos and digital media. Founded in 2012 and based in Silver Spring, Maryland, the company specializes in transforming personal memories, such as vacations and weddings, into dynamic films by combining various multimedia elements like photos, video clips, narration, music, and text. Users have the option to choose automated video creation or utilize editing features for a more customized experience. The final videos can be shared online, downloaded, or purchased as DVDs. In addition to serving individual customers, ReelGenie's technology also facilitates video storytelling for businesses, enhancing brand engagement and creating new revenue opportunities.

TerraGo

Series C in 2013
TerraGo Technologies specializes in software applications that enhance the accessibility and utility of maps and images for users without GIS expertise. The company serves over 850 organizations, including defense and intelligence agencies, utility companies, public safety departments, and environmental engineering teams. Its TerraGo Publisher Suite enables organizations to transform data from various sources into geo-enabled PDFs, known as GeoPDFs, facilitating better data consumption and optimization. Additionally, the TerraGo Collaboration Suite provides desktop, web-based, and mobile applications that streamline geospatial collaboration and information gathering, allowing clients to collect data, share insights, and collaborate effectively regardless of location or time constraints.

ViewLift

Venture Round in 2013
ViewLift is a comprehensive video streaming platform designed for publishers to effectively distribute and monetize their content across various digital devices, including mobile, OTT, IPTV, and Smart TVs. The platform enables companies to connect directly with consumers by streaming video content, thereby reaching targeted audiences in a dynamic media environment. ViewLift offers a range of features, including video monetization, analytics, and content distribution, allowing creators and brands to develop successful business models around their offerings. With its focus on custom branded native applications, ViewLift simplifies the process of engaging viewers and managing content across multiple platforms.

SnagFilms

Venture Round in 2013
SnagFilms Inc. is an online film distribution company that provides audiences with the opportunity to watch, share, and support a wide array of films and documentaries. Established in 2007 and headquartered in New York, the platform offers thousands of full-length movies, TV shows, and documentaries across various genres, including comedy, drama, science, and horror. Viewers can access content on multiple devices, including mobile phones, tablets, desktops, and TVs, and the service features multi-lingual options to cater to a diverse audience. SnagFilms aims to make independent and award-winning films accessible to a broader community while fostering a culture of support for filmmakers.

Speek

Seed Round in 2013
Speek Inc. is a provider of web-based conference calling solutions based in Dulles, Virginia. Founded in 2006, the company simplifies the conference calling experience by offering users a personal link that eliminates the need for dial-ins, pins, or downloads. Participants can join calls easily by clicking on a unique Speek link, allowing for seamless access via phone or web browser. The platform features a visual interface where users can see who has joined the call, identify active speakers, and share files. In its efforts to enhance its services, Speek has raised a total of $2.6 million in funding, including a recent $1.1 million in bridge funding. As of June 2015, Speek operates as a subsidiary of Jive Communications, Inc.

Revance Therapeutics

Series D in 2011
Revance Therapeutics is a biotechnology company that focuses on developing, manufacturing, and commercializing neuromodulators for aesthetic and therapeutic applications. Its primary product, DaxibotulinumtoxinA for injection (DAXI), is undergoing various clinical trials for treating conditions such as glabellar lines, cervical dystonia, adult upper limb spasticity, and plantar fasciitis, while also being explored for chronic migraine treatment. Additionally, Revance is developing topical formulations of DAXI and a biosimilar to BOTOX. The company has established collaborations for the development and commercialization of these products. Revance also offers a portfolio of aesthetic products, including the RHA Collection of dermal fillers and the HintMD platform. Founded in 1999 and headquartered in Newark, California, Revance Therapeutics was previously known as Essentia Biosystems.

FlyBy Media

Series A in 2010
FlyBy Media is a New York-based company founded in 2010 that specializes in developing augmented reality games and entertainment applications for mobile devices and platforms, including iPhone and Android. The company focuses on creating next-generation consumer mobile social applications that bridge the physical and digital worlds through innovative technology. Its team comprises mobile industry entrepreneurs and computer vision scientists committed to enhancing real-world experiences rather than replacing them. Additionally, FlyBy Media's proprietary computer vision technology integrates real-life interactions with mobile and wearable devices, fostering a unique connection between users and their environments.

Svelte Medical Systems

Debt Financing in 2009
Svelte Medical Systems, Inc. specializes in the design, development, and commercialization of balloon-expandable stents aimed at patients undergoing percutaneous coronary intervention (PCI) for atherosclerosis treatment. The company offers the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire system that simplifies catheter use for transradial interventions, and the DIRECT Rapid Exchange System, which employs proprietary balloon designs to improve direct stenting and post-dilatation processes. Founded in 2007 by Robert, David, and Tim Fischell, Svelte is committed to addressing critical clinical challenges in the coronary stent market, focusing on enhancing stent deliverability, reducing costs, and improving device safety. The company has developed one of the lowest profile and most deliverable stents available, featuring advanced technology aimed at achieving better clinical outcomes for patients. Based in New Providence, New Jersey, Svelte operates within the $5 billion coronary stent market.

TerraGo

Venture Round in 2009
TerraGo Technologies specializes in software applications that enhance the accessibility and utility of maps and images for users without GIS expertise. The company serves over 850 organizations, including defense and intelligence agencies, utility companies, public safety departments, and environmental engineering teams. Its TerraGo Publisher Suite enables organizations to transform data from various sources into geo-enabled PDFs, known as GeoPDFs, facilitating better data consumption and optimization. Additionally, the TerraGo Collaboration Suite provides desktop, web-based, and mobile applications that streamline geospatial collaboration and information gathering, allowing clients to collect data, share insights, and collaborate effectively regardless of location or time constraints.

Overture Technologies

Series C in 2008
Overture Technologies, Inc. develops and markets software solutions and consulting services to the residential lending and student financial aid industries. The company offers education finance solutions, including Conductor, an online financial aid solution, which provides personalized guidance, counseling, and services for students and their parents about their funding options; Student Loan Marketplace that enables users to compare loan terms from multiple lenders; and Amadeus, an underwriting and pricing solution for the student loan industry. It also provides Mortgage Finance Solutions, which promotes market efficiency and risk management for underwriting, pricing, servicing, and valuing mortgage loans and assets. The company's Mortgage Finance Solutions comprise Mozart for Special Servicing, which provides a set of alternatives for borrowers that can reduce repeat default rates and preserve the value of mortgage assets; Mozart for Acquisitions that calculates loan pools and portfolios worthiness; and Mozart for Originations, an automated underwriting system. Overture Technologies was founded in 2000 and is based in Bethesda, Maryland.

Aquestive Therapeutics

Debt Financing in 2008
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative products that address unmet medical needs both in the United States and internationally. The company's commercial portfolio features several oral soluble film formulations, including Sympazan for Lennox-Gastaut syndrome, Suboxone for opioid dependence, Exservan for Amyotrophic Lateral Sclerosis, and Zuplenz for chemotherapy-induced nausea and vomiting. Its pipeline includes advanced candidates such as Libervant, a buccal film for epileptic seizures, and various sublingual films aimed at treating conditions like anaphylaxis and Parkinson’s disease. Founded in 2004 and headquartered in Warren, New Jersey, Aquestive Therapeutics emphasizes its commitment to addressing critical healthcare challenges, particularly in Central Nervous System disorders, while also collaborating with pharmaceutical partners to enhance its product offerings.

Orchestro

Series C in 2008
Orchestro, Inc. is a provider of a Software-as-a-Service demand signal management platform designed for consumer packaged goods companies. Founded in 1999 and based in McLean, Virginia, the company specializes in data harmonization, facilitating in-store execution, new product introductions, on-shelf availability, promotion execution, and replenishment needs. Its platform consolidates point-of-sale, internal, and syndicated data, enabling users such as category analysts, national account managers, and international representatives to create informative dashboards. Orchestro was previously known as Vision Chain, Inc. and adopted its current name in February 2013. As of June 2016, it operates as a subsidiary of E2open, Inc.

Innovative Biosensors

Venture Round in 2008
Innovative Biosensors' technology is built upon a foundation of a genetically engineered biosensor that allows for extremely rapid testing of analytes, providing high levels of sensitivity and specificity. The patented, self-contained biosensor system is capable of generating a sensitive and specific result with minimal amount of reagents in minutes, making it a cost-effective alternative to traditional laboratory testing. In addition, the biosensors can be engineered to detect one target or several targets of interest simultaneously and used to perform a wide variety of bioassays. Designed for real-time detection, minimally-skilled personnel can perform tests and analysis at the site of sampling using small, portable, space-saving instrumentation

Digital Bridge Communications Corp.

Series B in 2008
Founded in late 2005, DigitalBridge Communications (DBC) provides broadband wireless to small and medium-sized communities of up to 150,000 people nationwide through the new WiMAX technology standard. In June 2007, DBC launched the first commercial WiMAX system in the United States in Rexburg, Idaho. Our strong, growing business benefits from the low-capital costs of WiMAX deployments and its high subscriber self-install rates. Building on the advantages of WiMAX economics, DBC has developed a highly scalable network deployment and variable-cost based back office platform that will enable us to bring broadband to communities nationwide. DBC is also committed to working with communities and schools to make high speed services available to local residents and students. We look forward to becoming an integral part of each community that we serve. We also expect to create partnerships with universities similar to our relationship with Ball State University in Muncie, Indiana. In January, 2007, Ball State University and DBC partnered to test licensed WiMAX self-install equipment. The test deployment was one of the first in the U.S. Since then, the collaboration continues to create the technical and business models needed to deliver WiMAX wireless broadband services profitably to traditionally underserved markets in Indiana and across the country.

Orchestro

Series C in 2007
Orchestro, Inc. is a provider of a Software-as-a-Service demand signal management platform designed for consumer packaged goods companies. Founded in 1999 and based in McLean, Virginia, the company specializes in data harmonization, facilitating in-store execution, new product introductions, on-shelf availability, promotion execution, and replenishment needs. Its platform consolidates point-of-sale, internal, and syndicated data, enabling users such as category analysts, national account managers, and international representatives to create informative dashboards. Orchestro was previously known as Vision Chain, Inc. and adopted its current name in February 2013. As of June 2016, it operates as a subsidiary of E2open, Inc.

Verax Biomedical

Series E in 2007
Verax Biomedical, Incorporated is a medical products company focused on developing rapid tests for detecting bacterial contamination in blood cells and tissues intended for transplantation and cellular therapies. Founded in 1999 and based in Marlborough, Massachusetts, the company addresses a critical need in the field of transfusion medicine, as traditional testing primarily targets viral contaminants, leaving bacterial risks largely unaddressed. Bacteria can proliferate in stored cellular materials, potentially growing from negligible levels at the time of collection to dangerous levels by the time of transfusion or transplantation. Verax Biomedical’s offerings include platelet and red cell Pan Genera Detection tests, designed to identify shared antigens found on various gram-positive and gram-negative bacteria. These tests enable blood banks to effectively detect and mitigate the risks associated with bacterial contamination, thereby enhancing the safety of blood transfusions and cellular therapies.

Aldagen

Series C in 2007
Aldagen is a biopharmaceutical company focused on developing proprietary regenerative cell therapies to address significant unmet medical needs. The company has four product candidates currently in clinical trials. The most advanced candidate, ALD-101, is undergoing a pivotal Phase 3 clinical trial to assess its efficacy in enhancing umbilical cord blood transplants for pediatric patients with inherited metabolic diseases. In addition, Aldagen is conducting or supporting Phase 1 or Phase 1/2 clinical trials for three other candidates: ALD-151, aimed at improving cord blood transplants for leukemia treatment; ALD-301, designed to address critical limb ischemia; and ALD-201, which targets ischemic heart failure.

TerraGo

Series A in 2007
TerraGo Technologies specializes in software applications that enhance the accessibility and utility of maps and images for users without GIS expertise. The company serves over 850 organizations, including defense and intelligence agencies, utility companies, public safety departments, and environmental engineering teams. Its TerraGo Publisher Suite enables organizations to transform data from various sources into geo-enabled PDFs, known as GeoPDFs, facilitating better data consumption and optimization. Additionally, the TerraGo Collaboration Suite provides desktop, web-based, and mobile applications that streamline geospatial collaboration and information gathering, allowing clients to collect data, share insights, and collaborate effectively regardless of location or time constraints.

Digital Bridge Communications Corp.

Series A in 2006
Founded in late 2005, DigitalBridge Communications (DBC) provides broadband wireless to small and medium-sized communities of up to 150,000 people nationwide through the new WiMAX technology standard. In June 2007, DBC launched the first commercial WiMAX system in the United States in Rexburg, Idaho. Our strong, growing business benefits from the low-capital costs of WiMAX deployments and its high subscriber self-install rates. Building on the advantages of WiMAX economics, DBC has developed a highly scalable network deployment and variable-cost based back office platform that will enable us to bring broadband to communities nationwide. DBC is also committed to working with communities and schools to make high speed services available to local residents and students. We look forward to becoming an integral part of each community that we serve. We also expect to create partnerships with universities similar to our relationship with Ball State University in Muncie, Indiana. In January, 2007, Ball State University and DBC partnered to test licensed WiMAX self-install equipment. The test deployment was one of the first in the U.S. Since then, the collaboration continues to create the technical and business models needed to deliver WiMAX wireless broadband services profitably to traditionally underserved markets in Indiana and across the country.

Prestwick Pharmaceuticals

Series C in 2006
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.

Overture Technologies

Series B in 2006
Overture Technologies, Inc. develops and markets software solutions and consulting services to the residential lending and student financial aid industries. The company offers education finance solutions, including Conductor, an online financial aid solution, which provides personalized guidance, counseling, and services for students and their parents about their funding options; Student Loan Marketplace that enables users to compare loan terms from multiple lenders; and Amadeus, an underwriting and pricing solution for the student loan industry. It also provides Mortgage Finance Solutions, which promotes market efficiency and risk management for underwriting, pricing, servicing, and valuing mortgage loans and assets. The company's Mortgage Finance Solutions comprise Mozart for Special Servicing, which provides a set of alternatives for borrowers that can reduce repeat default rates and preserve the value of mortgage assets; Mozart for Acquisitions that calculates loan pools and portfolios worthiness; and Mozart for Originations, an automated underwriting system. Overture Technologies was founded in 2000 and is based in Bethesda, Maryland.

Vital Sensors

Venture Round in 2006
Vital Sensors is a medical device company headquartered in Richmond, Virginia, focused on developing remote cardiac sensors specifically for patients with congestive heart failure. Founded in 2002, the company offers on-demand data monitoring services for individuals with cardiovascular diseases, both in hospital settings and at home. Vital Sensors' technology utilizes applications-specific spectroscopy to enhance its monitoring capabilities, ensuring that patients receive timely and accurate health information. The company's commitment to improving patient care through innovative monitoring solutions positions it as a significant player in the healthcare sector.

Verax Biomedical

Series B in 2005
Verax Biomedical, Incorporated is a medical products company focused on developing rapid tests for detecting bacterial contamination in blood cells and tissues intended for transplantation and cellular therapies. Founded in 1999 and based in Marlborough, Massachusetts, the company addresses a critical need in the field of transfusion medicine, as traditional testing primarily targets viral contaminants, leaving bacterial risks largely unaddressed. Bacteria can proliferate in stored cellular materials, potentially growing from negligible levels at the time of collection to dangerous levels by the time of transfusion or transplantation. Verax Biomedical’s offerings include platelet and red cell Pan Genera Detection tests, designed to identify shared antigens found on various gram-positive and gram-negative bacteria. These tests enable blood banks to effectively detect and mitigate the risks associated with bacterial contamination, thereby enhancing the safety of blood transfusions and cellular therapies.

Prestwick Pharmaceuticals

Series B in 2004
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.

PaylinX

Series B in 2000
PaylinX specializes in the design, development, and marketing of point-of-sale (POS) software solutions, with a focus on providing comprehensive support services for its products. The company offers a payment server that facilitates real-time authorization and settlement of credit card and other payment transactions. Its payment solutions empower businesses to accept and process transactions across various sales channels, including web storefronts, call centers, interactive voice response systems, in-store POS systems, and kiosks. Founded in 1994 and based in Foster City, California, PaylinX was acquired by Cybersource in July 2000, positioning itself as a key player in the evolving landscape of e-commerce payment services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.